Clinical data demonstrating safety and effectiveness is essential for all headache therapies. The Pulsante® System is the only neuromodulation therapy with published results demonstrating positive patient outcomes for episodic and chronic cluster headache sufferers. These outcomes include clinically significant improvement, frequency reduction, pain relief, improved quality-of-life and reduction in medication use.
For a complete list of clinical articles, click here.
- Schoenen, et al. Stimulation of the sphenopalatine ganglion (SPG) for cluster headache treatment. Pathway CH-1: A randomized, sham-controlled study. Cephalalgia, 2013; 33:816-30.
- Assaf, et al. Technical and surgical aspects of the sphenopalatine ganglion (SPG) microstimulator insertion procedure. International Journal of Oral & Maxillofacial Surgery, 2015.
- Jürgens, et al. Long-term effectiveness of sphenopalatine ganglion stimulation for cluster headache. Cephalalgia, 2016; 0:1-12.